TREM2+ macrophages accumulate in alveoli of human pulmonary tuberculosis providing a permissive niche for bacterial growth

This study reveals that TREM2+ lipid-laden macrophages accumulate in human pulmonary tuberculosis alveoli, creating a permissive niche for bacterial growth through PDIM-induced metabolic reprogramming that contrasts with the protective immunity of adjacent granulomas but can be reversed by vitamin D.

The Gist

The Big Picture: Two Different Worlds in One Lung

Imagine your lungs as a bustling city. When the bacteria that causes Tuberculosis (TB) invades, it doesn't just create one uniform mess. Instead, it creates two very different neighborhoods within the same city:

1. The "Granuloma" (The Fortress): This is the organized, fortified neighborhood that doctors have known about for centuries. It's like a high-security prison with thick walls, guards (immune cells), and a clear strategy to lock the bacteria away.
2. The "Alveolar Pneumonia" (The Open Market): This is the chaotic, early-stage area where the infection starts. It looks like a messy open market where the bacteria are running free, and the city's defenses are surprisingly weak.

The Main Discovery: This paper found that the bacteria aren't just hiding in the "Fortress." They are actually thriving in the "Open Market." The researchers discovered a specific type of immune cell called a TREM2+ Macrophage that acts like a "host with a bad habit," feeding the bacteria and helping them hide, rather than fighting them.

---

The Characters: The "Foamy" Macrophages

In the "Open Market" (the alveoli), the body sends in its cleanup crew: Macrophages. Think of these as the city's garbage collectors and security guards.

• The Good Guards (in the Fortress): In the organized granulomas, the guards are alert, angry, and armed with weapons (antimicrobial proteins). They are trying to kill the bacteria.
• The "Foamy" Guards (in the Pneumonia): In the early pneumonia, the guards get confused. They start eating too much fat (lipids) and turn into "Foamy Macrophages."
  • The Analogy: Imagine a security guard who gets so distracted by a buffet of free food that they stop patrolling and start stuffing their pockets. They become "foamy" (full of fat droplets) and lethargic.
  • The Problem: These "Foamy Guards" are actually TREM2+ Macrophages. They have a specific receptor (TREM2) that acts like a "Do Not Disturb" sign. Instead of killing the bacteria, they let the bacteria live inside them, using the fat as fuel.

The Villain's Trick: The Bacterial "Key"

How do the bacteria trick the guards into becoming "Foamy"?

The TB bacteria have a special weapon in their armor called PDIM (a type of lipid/fat).

• The Metaphor: Imagine the bacteria are thieves wearing a disguise. They wear a specific "key" (PDIM) that fits perfectly into the "Do Not Disturb" lock (TREM2) on the guard's door.
• The Result: When the bacteria insert this key, it tells the guard: "Relax, eat some fat, and don't fight." This triggers the guard to stop fighting, fill up with fat, and become a safe, cozy home for the bacteria to multiply.

The Evidence: Where are the Bacteria?

The researchers used high-tech "microscopes" (spatial transcriptomics and imaging) to look at human lung tissue. They found:

• In the Fortress (Granulomas): Very few bacteria. The guards are working hard, and the bacteria are starving or dead.
• In the Open Market (Pneumonia): The "Foamy Guards" are packed with bacteria. The researchers could see the bacteria's genetic code (RNA) and antigens (protein parts) inside these fat-filled cells.
• The Surprise: Even though these patients often tested negative for TB on standard sputum tests (because the bacteria were hidden inside the cells and not coughing up), the lung tissue was actually teeming with active bacteria.

The Solution: Flipping the Switch

The most exciting part of the paper is that this "bad habit" of the guards isn't permanent. The researchers tested a treatment using Vitamin D.

• The Analogy: Think of Vitamin D as a "Wake Up Call" or a "System Reboot."
• What Happened: When they treated the "Foamy Guards" with Vitamin D in the lab:
  1. The "Do Not Disturb" sign (TREM2) was removed.
  2. The guards stopped eating so much fat (lipid droplets disappeared).
  3. The guards turned their "trash compactors" (autophagy) back on.
  4. The Result: The bacteria inside the guards started dying off. The Vitamin D turned the "hostile" environment back into a "hostile" one for the bacteria.

Why Does This Matter?

1. Why TB is Hard to Cure: TB often hides in these "Open Market" areas before the body builds the "Fortress." Because the bacteria are hiding in fat-filled cells that aren't being attacked, they can survive and spread even when the patient feels fine.
2. New Treatment Ideas: Current drugs kill bacteria, but they don't fix the "bad behavior" of the immune cells. This paper suggests that we could use Host-Directed Therapy. Instead of just attacking the bacteria, we could give patients Vitamin D (or similar drugs) to wake up the "Foamy Guards" and help them fight the infection naturally.
3. Transmission: Because these "Open Markets" are right next to the airways, the bacteria living there can easily be coughed out and spread to others, even if the patient doesn't have a big, visible lump (granuloma) in their lung yet.

Summary in One Sentence

This study reveals that early TB infection creates a "safe house" of fat-filled immune cells that feed the bacteria, but we might be able to break down this safe house and wake up the immune system using Vitamin D.

Technical Summary

1. Problem Statement

Pulmonary tuberculosis (TB) is characterized by spatial heterogeneity, where organized granulomas and exudative alveolar pneumonia often coexist within the same lung. While the immune mechanisms governing granulomas (the "containment" lesion) are well-studied, the immunological and metabolic programs operating within the alveolar pneumonia phase of human TB remain poorly defined. Historically, alveolar pneumonia has been viewed as an early precursor to granuloma formation, but its specific cellular composition, bacterial burden, and role in bacterial persistence and transmission are not fully understood. The authors hypothesize that the alveolar niche harbors a distinct macrophage population that creates a permissive environment for Mycobacterium tuberculosis (Mtb) survival, contrasting sharply with the antimicrobial environment of granulomas.

2. Methodology

The study employed a multi-modal, high-resolution approach integrating human tissue analysis with in vitro functional assays:

• Human Cohort: Lung biopsies were obtained from four patients with untreated, suspected pulmonary TB (diagnosed via biopsy due to negative sputum smears). These samples contained both acute alveolar pneumonia and adjacent organized granulomas.
• Spatial Transcriptomics (GeoMx DSP): Micro-dissected Regions of Interest (ROIs) from alveolar pneumonia, granuloma cores, and granuloma mantles were profiled for >18,000 genes to define region-specific transcriptional signatures.
• Single-Cell RNA Sequencing (scRNA-seq): Performed on Formalin-Fixed Paraffin-Embedded (FFPE) tissue to identify and cluster ~45,000 cells across four patients, defining specific cell populations (e.g., macrophage subsets, T cells).
• Spatial Proteomics (NanoString CosMx): High-plex imaging (64 proteins) and immunohistochemistry/immunofluorescence were used to validate cell localization, protein expression (TREM2, CD163, PLIN2), and bacterial antigen presence (LAM, PPD) at subcellular resolution.
• In Situ Hybridization (RNAscope): Used to detect Mtb mRNA transcripts (e.g., esxA, fbpB) within specific tissue compartments.
• In Vitro Functional Assays:
  • Macrophage Polarization: Human monocyte-derived macrophages (MDMs) were differentiated with IL-4 to induce a TREM2+ foamy phenotype.
  • Ligand Stimulation: Cells were exposed to Mtb lipids (PDIM, free mycolic acids, LAM, peptidoglycan) to test induction of TREM2 and signaling.
  • TREM2 Signaling Reporter: A 2B4-DAP12-GFP reporter cell line was used to confirm direct TREM2-DAP12 pathway activation by Mtb lipids.
  • Bacterial Viability: Dual-fluorescent Mtb strains (mCherry for total bacteria, GFP for live/metabolically active bacteria) were used to quantify intracellular survival in TREM2+ vs. control macrophages.
  • Intervention: Macrophages were treated with 1,25-dihydroxyvitamin D₃ (calcitriol) to test reversibility of the permissive state.
  • Metabolic/Functional Readouts: Lipid droplet quantification (Oil Red O, SMCy5.5), autophagy assessment (LC3 puncta), and Colony Forming Unit (CFU) assays.

3. Key Contributions

• Spatial Definition of TB Lesions: The study definitively maps the molecular and cellular landscape of human TB, distinguishing the alveolar pneumonia compartment from the granuloma compartment within the same patient.
• Identification of a Permissive Niche: It identifies TREM2+ lipid-associated macrophages as the dominant cell type in alveolar pneumonia, characterized by lipid metabolic reprogramming and a lack of antimicrobial gene expression.
• Mechanistic Link to Virulence Factors: The paper establishes that specific Mtb virulence lipids, Phthiocerol Dimycocerosate (PDIM) and free mycolic acids, are direct ligands that induce TREM2 expression and activate TREM2-DAP12 signaling, driving the foamy macrophage phenotype.
• Reversibility of the Niche: It demonstrates that the permissive TREM2+ state is pharmacologically reversible via Vitamin D3, which downregulates TREM2, restores autophagy, and reduces bacterial viability.

4. Key Results

A. Spatial and Transcriptional Heterogeneity

• Alveolar Pneumonia: Enriched for TREM2+ macrophages expressing lipid metabolism genes (APOE, APOC1, LIPA, CD36, CD163) and surfactant proteins. These regions showed sparse T-cell infiltration and minimal expression of antimicrobial peptides (only 3/52 detected).
• Granuloma Cores: Enriched for IFN-γ-activated macrophages, SPP1+ macrophages, and Th17 cells. These regions exhibited robust expression of antimicrobial genes (e.g., IL1B, CYP27B1, CAMP, CYBB) and a concentrated antimicrobial profile (15/52 genes detected).
• Bacterial Burden: Contrary to the assumption that granulomas are the primary reservoir, Mtb mRNA and antigens (LAM, PPD) were most abundant in the alveolar pneumonia, specifically co-localizing with TREM2+ foamy macrophages. Granuloma cores showed sparse bacterial signals.

B. Phenotype of TREM2+ Macrophages

• Foamy Morphology: TREM2+ cells in alveoli were CD163+, PLIN2+ (lipid droplet marker), and contained abundant intracellular lipid droplets.
• Bacterial Reservoir: RNAscope confirmed that these TREM2+ foamy macrophages harbor high loads of Mtb mRNA, indicating active bacterial persistence.
• Lipid Metabolism: The TREM2+ signature was highly conserved with lipid-associated macrophages found in leprosy and other lipid-rich pathologies.

C. Mechanism of Induction and Signaling

• Ligand Specificity: Among Mtb components, PDIM and free mycolic acids potently induced TREM2 surface expression and triggered TREM2-DAP12 signaling (measured by GFP reporter). LAM and peptidoglycan did not.
• Signaling Pathway: PDIM and mycolic acids activated the TREM2-DAP12-PI3K-AKT-mTOR axis, leading to lipid droplet accumulation and suppression of autophagy.
• Functional Outcome: TREM2+ foamy macrophages harbored ~2x more viable (GFP+) Mtb than unpolarized controls. There was a strong positive correlation between lipid droplet abundance and bacterial viability, and an inverse correlation with autophagy (LC3).

D. Pharmacological Reversibility

• Vitamin D3 Intervention: Treatment with 1,25-dihydroxyvitamin D₃ significantly downregulated TREM2 expression, reduced lipid droplet content (~40-55%), and restored autophagy (increased LC3 puncta).
• Bacterial Control: Vitamin D3 treatment reduced intracellular Mtb viability by approximately 1 log₁₀ in CFU assays and shifted the population toward bacteria-restricted macrophages, proving the permissive niche is modifiable.

5. Significance

• Redefining TB Pathogenesis: The study challenges the granuloma-centric view of TB, proposing that alveolar pneumonia dominated by TREM2+ foamy macrophages is the primary site of early bacterial expansion and persistence.
• Transmission Implications: Since alveolar pneumonia is located at the air-lung interface and often lacks the containment of granulomas, this permissive niche may explain how Mtb expands and is exhaled by patients who are culture-negative or asymptomatic, facilitating transmission.
• Therapeutic Target: The identification of the TREM2-DAP12 axis as a driver of bacterial persistence offers a novel target for Host-Directed Therapy (HDT). The finding that Vitamin D3 can reverse this state suggests potential for repurposing or developing agents that block TREM2 signaling to enhance bacterial clearance.
• Diagnostic Insight: The presence of abundant Mtb mRNA in alveolar lesions despite negative sputum smears highlights the need for tissue-based molecular diagnostics in atypical TB presentations.

In summary, this paper provides a comprehensive molecular and functional map of human TB, revealing that Mtb actively co-opts host macrophages via PDIM-induced TREM2 signaling to create a lipid-rich, immunosuppressed alveolar niche that supports bacterial survival and transmission.